Complications of therapeutic apheresis in pediatric kidney transplantation

De Palo, 2000, Therapeutic apheresis in children: experience in a pediatric dialysis center, Int J Artif Organs, 23, 834, 10.1177/039139880002301209

Michon, 2007, Complications of apheresis in children, Transfusion, 47, 1837, 10.1111/j.1537-2995.2007.01405.x

Mokrzycki, 1994, Therapeutic plasma exchange: complications and management, Am J Kidney Dis, 23, 817, 10.1016/S0272-6386(12)80135-1

Dhakal, 2017, Eculizumab in transplant-associated thrombotic microangiopathy, Clin Appl Thromb Hemost, 23, 175, 10.1177/1076029615599439

Janeway, 1999

Wing, 1980, Infectious complications with plasmapheresis in rapidly progressive glomerulonephritis, JAMA, 244, 2423, 10.1001/jama.1980.03310210025020

Singer, 1987, Infective complications of plasma exchange: a prospective study, Arthritis Rheum, 30, 443, 10.1002/art.1780300413

Pohl, 1991, Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group, Ann Intern Med, 114, 924, 10.7326/0003-4819-114-11-924

Slatinska, 2010, Plasmapheresis and intravenous immunoglobulin in the treatment and prevention of antibody mediated rejection, Transplantationsmedizin, S277

Waiser, 2016, Rituximab in combination with bortezomib, plasmapheresis, and high-dose IVIG to treat antibody-mediated renal allograft rejection, Transplant Direct, 2, e91, 10.1097/TXD.0000000000000604

Dau, 1995, Increased antibody production in peripheral blood mononuclear cells after plasma exchange therapy in multiple sclerosis, J Neuroimmunol, 62, 197, 10.1016/0165-5728(95)00121-4

Lefaucheur, 2009, Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection, Am J Transplant, 9, 1099, 10.1111/j.1600-6143.2009.02591.x

Yamada, 2015, Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients, Transfusion, 55, 727, 10.1111/trf.12923

Paglieroni, 1987, Effects of plasmapheresis on peripheral blood mononuclear cell populations from patients with macroglobulinemia, J Clin Apher, 3, 202, 10.1002/jca.2920030403

Walsh, 2010, Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection, Transplantation, 89, 277, 10.1097/TP.0b013e3181c6ff8d

Ibrahim, 2007, Drug removal by plasmapheresis: an evidence-based review, Pharmacotherapy, 27, 1529, 10.1592/phco.27.11.1529

Puisset, 2013, Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease, Br J Clin Pharmacol, 76, 734, 10.1111/bcp.12098

Lee, 2012, Anticoagulation techniques in apheresis: from heparin to citrate and beyond, J Clin Apher, 27, 117, 10.1002/jca.21222

Kasprisin, 1989, Techniques, indications, and toxicity of therapeutic hemapheresis in children, J Clin Apher, 5, 21, 10.1002/jca.2920050108

Goss, 1999, Pentastarch as partial replacement fluid for therapeutic plasma exchange: effect on plasma proteins, adverse events during treatment, and serum ionized calcium, J Clin Apher, 14, 114, 10.1002/(SICI)1098-1101(1999)14:3<114::AID-JCA2>3.0.CO;2-8

Kankirawatana, 2007, Continuous infusion of calcium gluconate in 5% albumin is safe and prevents most hypocalcemic reactions during therapeutic plasma exchange, J Clin Apher, 22, 265, 10.1002/jca.20142

Kiprov, 2001, Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures, J Clin Apher, 16, 130, 10.1002/jca.1024

Marques, 2001, Patients with thrombotic thrombocytopenic purpura commonly develop metabolic alkalosis during therapeutic plasma exchange, J Clin Apher, 16, 120, 10.1002/jca.1022

Goldstein, 2012, Therapeutic apheresis in children: special considerations, Semin Dial, 25, 165, 10.1111/j.1525-139X.2011.01028.x

Krieter, 2005, Contact activation in low-density lipoprotein apheresis systems, Artif Organs, 29, 47, 10.1111/j.1525-1594.2004.29007.x

Zöllner, 2014, Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two, Blood Purif, 38, 160, 10.1159/000367682

Mathis, 2004, Bleeding and thrombosis in high-risk renal transplantation candidates using heparin, Ann Pharmacother, 38, 537, 10.1345/aph.1D510

Morrissey, 2002, Management of thrombophilia in renal transplant patients, Am J Transplant, 2, 872, 10.1034/j.1600-6143.2002.20910.x

Vidal, 2017, Therapeutic plasma exchange in neonates and infants: successful use of a miniaturized machine, Blood Purif, 44, 100, 10.1159/000470827

Nahum, 2002, Efficacy of subcutaneous tunneling for prevention of bacterial colonization of femoral central venous catheters in critically ill children, Pediatr Infect Dis J, 21, 1000, 10.1097/00006454-200211000-00005